New Launch5 Dec 2025, 03:18 pm
Senores Pharmaceuticals receives Philippine FDA approval for 10 products, expanding Southeast Asia footprint
AI Summary
Senores Pharmaceuticals Limited has received marketing authorizations from the Philippine Food and Drug Administration (FDA) for a basket of 10 products across Therapies like Cardiovascular, CNS, and Pain management, etc. This marks a significant step in the company’s strategy to expand its footprint in Southeast Asia and enhance access to affordable healthcare. The approvals provide Senores Pharmaceuticals with a strong platform to serve the Philippines, a market size of these particular drugs in the Philippines is valued at US $23 million. The company is committed to delivering high-quality, affordable treatments for patients and improving treatment outcomes and broadening patient access in the Asia-Pacific region.
Key Highlights
- Senores Pharmaceuticals received marketing authorizations from the Philippine FDA for 10 products
- The approved products are across Therapies like Cardiovascular, CNS, and Pain management
- This move is a significant step in the company’s strategy to expand its footprint in Southeast Asia
- The market size of these particular drugs in the Philippines is valued at US $23 million
- Senores Pharmaceuticals is committed to delivering high-quality, affordable treatments for patients